Menu
Tri-Institutional MD-PhD Program
Found 4 results
Filters: Keyword is Prostatic Neoplasms  [Clear All Filters]
2025
Mao N, Lee YSun, Salsabeel N, Zhang Z, Li D, Kaur H, Chen X, Chang Q, Mehta S, Barnes J et al..  2025.  Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers.. Sci Adv. 11(6):eadq3802.
2018
Chohan MOmar, Kahn S, Cederquist G, Reiner AS, Schwab J, Laufer I, Bilsky M.  2018.  Surgical Decompression of High-Grade Spinal Cord Compression from Hormone Refractory Metastatic Prostate Cancer.. Neurosurgery. 82(5):670-677.
2017
Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC et al..  2017.  Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.. Cancer Discov. 7(7):750-765.
2013
Cooperberg MR, Ramakrishna NR, Duff SB, Hughes KE, Sadownik S, Smith JA, Tewari AK.  2013.  Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.. BJU Int. 111(3):437-50.